AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 82 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $19,000 | -17.4% | 318,836 | +133.6% | 0.00% | – |
| Q2 2022 | $23,000 | -23.3% | 136,486 | +645.6% | 0.00% | – |
| Q3 2021 | $30,000 | -91.1% | 18,306 | -90.9% | 0.00% | – |
| Q2 2021 | $336,000 | +1192.3% | 201,567 | +1207.2% | 0.00% | – |
| Q1 2021 | $26,000 | -82.6% | 15,420 | -83.5% | 0.00% | – |
| Q4 2020 | $149,000 | +1555.6% | 93,451 | +318.6% | 0.00% | – |
| Q1 2020 | $9,000 | -94.6% | 22,322 | -94.8% | 0.00% | – |
| Q2 2019 | $166,000 | +621.7% | 426,932 | +858.3% | 0.00% | – |
| Q3 2018 | $23,000 | -55.8% | 44,553 | +193.1% | 0.00% | – |
| Q1 2018 | $52,000 | -48.5% | 15,200 | -64.3% | 0.00% | -100.0% |
| Q2 2015 | $101,000 | – | 42,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,595,484 | $10,564,000 | 9.31% |
| Cypress Capital Management LLC (WY) | 108,400 | $441,000 | 0.50% |
| Noven Financial Group, Inc. | 158,059 | $643,000 | 0.37% |
| Transform Wealth, LLC | 205,481 | $836,000 | 0.15% |
| GHP Investment Advisors, Inc. | 100,000 | $407,000 | 0.06% |
| Pratt Collard Advisory Partners LLC | 15,600 | $63,000 | 0.05% |
| JANICZEK WEALTH MANAGEMENT, LLC | 16,719 | $68,000 | 0.04% |
| Virtu Financial LLC | 92,344 | $376,000 | 0.02% |
| JFS WEALTH ADVISORS, LLC | 18,150 | $74,000 | 0.02% |
| CONDOR CAPITAL MANAGEMENT | 21,400 | $87,000 | 0.02% |